PYXS vs T · rev $2.8M vs P/E 7.4, rev $32.02B
Pyxis Oncology Inc (PYXS) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported T revenue for 2023-12-31 was $32.02B. Revenue was up 2.2% from 2022-12-31 to 2023-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
PYXS currently screens at market cap $109.6M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the PYXS and T stock pages for the full models.
Not investment advice.